- 23 January 2019
- Posted by: invamed
- Category: Blog
The clot may form locally in an artery and block it (thrombosis) or clot may occur in another part of the body and is transported in the bloodstream until it stops in a distant artery (embolism). Clotting with clot prevents normal blood flow to the organ presented by the artery, resulting in ischemia (tissue hunger) or necrosis (tissue death).
An artery usually a femoral artery is inserted with a small hole and X-rays are used to navigate through a clogged artery in a catheter. A special infusion catheter is located in or inside the clot and a strong anticoagulant drug (thrombolysis) is added to the clot to dissolve. Follow-up angiography is typically performed in 12-24 hours to determine the success of thrombolysis.
Bleeding, infection, damage to the artery wall (tearing or dissection). The clot or plaque may break during intervention and may limit the flow (distal embolization) to the foot. In most cases, these complications can be noticed and treated during the procedure. Rarely open surgery or amputation may be required.
During thrombolysis, the patient is regularly at bed rest on a monitored unit, with vital signs and puncture sites. After arterial thrombolysis is completed, the area of arterial puncture is closed and the patient should lie flat for two to six hours. Anticoagulation is often performed to help keep the treated arteries open.
Doppler ultrasonography and clinic visits are typically performed a few weeks after the procedure to verify that the artery remains open and symptoms have improved. Attendance tracking depends on the individual situation.
Mantis Curve provides many advantages for the treatment process. Some of these advantages include:
The battery-operated hand-held system initiates mechanical rotation of the atraumatic unique ring shape by aspiration.
It protects the vessel wall with its leaf-shaped end design. It also creates a vortex effect to prevent thrombus with distal embolism and TPA. The internal infusion port provides infusion of TPA and contrast media. The tip diameter of the tip diameter can be adjusted from 5 to 20 mm in diameter. It allows the physician to perform treatment depending on the field of application and vessel size. Significantly reduces the dose of thrombolytic therapy. It significantly prevents post-thrombolytic syndrome and, most importantly, provides a significant advantage for the patient by reducing the length of hospital stay.